For example, the low expression of BTG1 might be involved in the progression of pancreatic ductal adenocarcinoma, suggesting that BTG1 might be a poor prognostic marker of the survival rate in cancer [85]. Here, BTG1 is linked to pancreatic ductal adenocarcinoma.